文献速递消化、代谢与肾脏急症重症综合管理与镇静镇痛

分泌型白细胞蛋白酶抑制剂抑制脂多糖诱导的人近端肾小管细胞炎症反应与凋亡

[Secretory leukocyte peptidase inhibitor inhibits the inflammatory response and apoptosis of lipopolysaccharide-induced human proximal renal tubular cells].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2022-01-01
一句话结论生物信息学筛选及细胞实验提示SLPI可抑制LPS诱导的HK2细胞炎症因子释放与凋亡,是脓毒症相关AKI的潜在治疗靶点。

该研究先用GSE30718和GSE53773两个数据集行生物信息学分析,筛选出在两者中表达差异一致且ROC曲线下面积较高的基因,SLPI在GSE30718和GSE53773中的AUC分别为0.83和0.92,被选为目标基因。随后在体外培养的人近端肾小管细胞HK2中用LPS 10 mg/L作用6小时建立LPS-HK2模型,以siRNA敲低SLPI。结果显示LPS模型组SLPI表达高于空白对照组(2-ΔΔCT:1.80±0.14 vs. 1.00±0.11,P<0.01);敲低SLPI后IL-6、IL-1β、TNF-α水平及Bax、caspase-3表达均较阴性对照组升高,Bcl-2表达降低。作者认为SLPI可抑制LPS诱导的HK2细胞炎症反应与凋亡,可能参与脓毒症时肾小管细胞的保护机制,是脓毒症相关AKI的潜在治疗靶点。

要点

  • 生物信息学分析中SLPI在GSE30718和GSE53773数据集对AKI的诊断AUC分别为0.83和0.92,被选为后续细胞验证的目标基因。
  • LPS-HK2模型组SLPI表达显著高于空白对照组(2-ΔΔCT:1.80±0.14 vs. 1.00±0.11,P<0.01),趋势与生物信息学分析一致。
  • 敲低SLPI后LPS-HK2细胞上清IL-6(509.58±27.08 vs. 253.87±75.83 ng/L)、IL-1β(490.99±49.52 vs. 239.67±26.97 ng/L)、TNF-α(755.22±48.66 vs. 502.06±10.92 ng/L)均高于阴性对照组,均P<0.01。
  • 敲低SLPI后Bax(1.38±0.12 vs. 1.00±0.10,P<0.05)和caspase-3(1.44±0.15 vs. 1.00±0.11,P<0.05)表达升高,Bcl-2表达降低(0.83±0.08 vs. 1.00±0.05,P<0.05)。
  • 作者认为SLPI可抑制LPS诱导的HK2细胞炎症反应与凋亡,是脓毒症相关AKI的潜在治疗靶点。

适用人群与场景

  • 体外培养的人近端肾小管细胞HK2,用于建立LPS-HK2细胞模型;生物信息学部分为肾移植前后肾活检mRNA芯片数据中移植后发生AKI的患者亚组。

诊断标准与关键阈值

  • LPS-HK2细胞模型:LPS 10 mg/L作用6小时。
  • 目标基因筛选条件:两个数据集中差异表达趋势一致且ROC曲线下面积较高,SLPI在GSE30718和GSE53773中的AUC分别为0.83和0.92。

处置流程与药物剂量

  • 以siRNA技术敲低LPS-HK2细胞中的SLPI(基因敲低组),并设基因阴性对照组。
  • 用RT-qPCR检测HK2细胞中目标基因表达,ELISA检测细胞上清炎症因子水平,Western blotting检测关键凋亡蛋白表达。

研究设计与关键结果

  • 生物信息学分析:两个数据集中325个基因表达趋势相同,其中144个显著下调、181个显著上调,SLPI在两个数据集中的表达差异均有统计学意义;ROC分析示GSE30718和GSE53773中SLPI对AKI诊断的AUC分别为0.83和0.92。
  • 细胞验证:LPS模型组HK2细胞SLPI表达显著高于空白对照组(2-ΔΔCT:1.80±0.14 vs. 1.00±0.11,P<0.01)。
  • 敲低SLPI后,LPS-HK2细胞上清IL-6(509.58±27.08 vs. 253.87±75.83 ng/L)、IL-1β(490.99±49.52 vs. 239.67±26.97 ng/L)、TNF-α(755.22±48.66 vs. 502.06±10.92 ng/L)均显著高于阴性对照组,均P<0.01。
  • 敲低SLPI后,Bax蛋白(Bax/GAPDH:1.38±0.12 vs. 1.00±0.10,P<0.05)和caspase-3蛋白(caspase-3/GAPDH:1.44±0.15 vs. 1.00±0.11,P<0.05)表达显著高于阴性对照组,Bcl-2表达显著降低(Bcl-2/GAPDH:0.83±0.08 vs. 1.00±0.05,P<0.05)。

证据类型、等级与局限

  • 证据类型:生物信息学分析联合体外细胞实验(基础研究)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为SLPI可抑制LPS诱导的HK2细胞炎症反应与凋亡,可能参与脓毒症时肾小管细胞的保护机制,是脓毒症相关AKI的潜在治疗靶点。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To screen out the potential key genes of sepsis-associated acute kidney injury (AKI), and provide theoretical and experimental evidence for the treatment of sepsis-associated AKI.

METHODS: (1) Bioinformatics analysis: two gene expression datasets (GSE30718 and GSE53773) were downloaded for bioinformatics analysis from the Gene Expression Omnibus (GEO). These two datasets recorded mRNA microarray data from kidney biopsies before and after kidney transplantation, and a subset of patients developed AKI after kidney transplantation. Differential analysis was conducted, and the genes with the same differential expression and a higher area under the receiver operator characteristic curve (AUC) in both databases were used as the target gene for subsequent cell experiments. (2) Cell validation experiment: human proximal renal tubular cells HK2 were cultured in vitro, and lipopolysaccharide (LPS) was used for establishing LPS-HK2 cell model (LPS 10 mg/L for 6 hours, LPS model group), and the blank control group was set. Then, small interfering RNA (siRNA) technology was used to knock down the target gene obtained by bioinformatics analysis in LPS-HK2 cells (gene knockdown group), and a gene negative control group was set. The real-time fluorescent quantitative reverse transcription-polymerase chain reaction (RT-qPCR) technique was used to detect the expression of the target gene in HK2 cells. Enzyme-linked immunosorbent assay (ELISA) was used to detect the levels of inflammatory factors in the cell supernatants. Western blotting was used to detect the expressions of key apoptosis proteins.

RESULTS: (1) Results of bioinformatics analysis: 325 genes in the two datasets showed the same expression trend, of which 144 were significantly down-regulated and 181 were significantly up-regulated, while the expression difference of secretory leukocyte protease inhibitor (SLPI) in the two datasets was both statistically significant. Further receiver operator characteristic curve (ROC curve) analysis confirmed that the SLPI expression in GSE30718 and GSE53773 datasets had a high diagnostic efficiency for AKI, with AUC of 0.83 and 0.92, respectively. Therefore, SLPI was selected as the target gene for subsequent cell validation experiment. (2) Cell validation experiment: the RT-qPCR analysis showed that the expression of SLPI in LPS-HK2 cells of the LPS model group was significantly higher than that of the blank control group (2-ΔΔCT: 1.80±0.14 vs. 1.00±0.11, P < 0.01), and the change trend was the same with the results of bioinformatics analysis. Furthermore, knockdown SLPI gene analysis showed that the levels of inflammatory factors in LPS-HK2 cells supernatants in the gene knockdown group were significantly higher than those in the negative control group [Interleukin-6 (IL-6, ng/L): 509.58±27.08 vs. 253.87±75.83, IL-1β (ng/L): 490.99±49.52 vs. 239.67±26.97, tumor necrosis factor-α (TNF-α, ng/L): 755.22±48.66 vs. 502.06±10.92, all P < 0.01]. The above results indicated that SLPI could inhibit the inflammatory response of HK2 cells induced by LPS. The expressions of key apoptosis proteins Bax and caspase-3 in LPS-HK2 cells in the gene knockdown group were significantly higher than those in the negative control group [Bax protein (Bax/GAPDH): 1.38±0.12 vs. 1.00±0.10, caspase-3 protein (caspase-3/GAPDH): 1.44±0.15 vs. 1.00±0.11, both P < 0.05], and Bcl-2 expression was significantly decreased (Bcl-2/GAPDH: 0.83±0.08 vs. 1.00±0.05, P < 0.05), the above results indicated that SLPI could inhibit the apoptosis of cells in the inflammatory response.

CONCLUSIONS: SLPI can inhibit the inflammatory response and apoptosis of HK2 cells induced by LPS, which may be involved in the protective mechanism of renal tubular cells in the response to sepsis, and is a potential target for the treatment of sepsis-associated AKI.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Zhang D, Wang W, Shao R, et al. [Secretory leukocyte peptidase inhibitor inhibits the inflammatory response and apoptosis of lipopolysaccharide-induced human proximal renal tubular cells]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2022. PMID: 36100410. doi:10.3760/cma.j.cn121430-20210903-01315

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。